Investigative Site

Tampa, Florida 33634

1 studies enrolling now · 12 studies all time

What they study most

CLE, Chronic Idiopathic Constipation, Constipation, Covid19, Cutaneous Lupus Erythematosus (CLE), Diabetic Macular Edema, Hidradenitis Suppurativa, Irritable Bowel Syndrome With Diarrhea (IBS-D), Opioid-induced Constipation, Overactive Bladder (OAB), Postherpetic Neuralgia, SLE

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — Recruiting now
• A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME) — Running, not enrolling
• Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19. — Stopped early
• Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19 — Completed
• VIR-7831 for the Early Treatment of COVID-19 in Outpatients — Completed
• A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa — Completed
• Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo — Completed
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia — Completed
• Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. — Stopped early
• Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain — Stopped early
• Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder — Completed